The Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Saez-Alegre M, Garcia-Feijoo P, Millan P, Vivancos Sanchez C, Dominguez V, Garcia Nerin J Front Neurol. 2021; 12:632036.
PMID: 33692744 PMC: 7937865. DOI: 10.3389/fneur.2021.632036.
References
1.
Dinger J, Assmann A, Mohner S, Minh T
. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care. 2010; 36(3):123-9.
DOI: 10.1783/147118910791749416.
View
2.
Parkin L, Sharples K, Hernandez R, Jick S
. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ. 2011; 342:d2139.
PMC: 3081041.
DOI: 10.1136/bmj.d2139.
View
3.
Gronich N, Lavi I, Rennert G
. Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. CMAJ. 2011; 183(18):E1319-25.
PMC: 3255137.
DOI: 10.1503/cmaj.110463.
View
4.
Martinez F, Ramirez I, Perez-Campos E, Latorre K, Lete I
. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2012; 17(1):7-29.
DOI: 10.3109/13625187.2011.643836.
View
5.
Manzoli L, De Vito C, Marzuillo C, Boccia A, Villari P
. Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis. Drug Saf. 2012; 35(3):191-205.
DOI: 10.2165/11598050-000000000-00000.
View